drugset / Trial / NCT05988814

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

NCT05988814 ↗

Phase 2 Recruiting 90 enrolled Centre Georges Francois Leclerc
NaSingle-groupOpen-labelTreatment

Summary

Evaluate the efficacy of treatment FOLFORINOX 3 in first-line therapy for patients with locally advanced unresectable or metastatic pancreatic cancer.

Timeline

Start
2024-01-24
Primary completion
2029-07-24
Completion
2029-07-24

Drugs

EvaluationDrugModalityDoseRoute
Background Leucovorin Small molecule — —
Background fluorouracil Small molecule — —